Stoic Venture Capital invests in nanotech Ferronova

August 2020: Stoic Venture Capital has taken part in a $3.5m Series A funding round for Australian biotechnology company Ferronova Pty Ltd.

 

The funding round was led by Uniseed, where Stoic Venture Capital is the co-investment fund. Uniseed is a commercialisation fund which focuses on financing early-stage companies that emerge from member universities.

 

Ferronova’s technology has the potential to transform care for early stage cancer patients in complex cancers such as colorectal cancer. The company originated from landmark research by the Victoria University of Wellington and the University of South Australia.

 

Stoic Venture Capital Partner Geoff Waring said the venture capital fund’s portfolio expanded dramatically to a total of 17 companies in the past two years with a primary focus on healthcare.

 

 

 

“Ferronova is a visionary Australian company with technology solutions that are advancing the detection, diagnosis and treatment of early stage cancer,” Dr Waring said.

 

“We support the growth of healthcare companies that are changing outcomes and improving the lives of patients.”

 

Dr Waring said Stoic Venture Capital would continue to have a big allocation to healthcare opportunities.

 

“Healthcare remains a resilient and high potential asset class. Evidence-backed medical technology creates alternative models of care and prevention.”

 

“Importantly, our investments are also contributing to the pioneering of new research and development in medicine and science to help more patients in the future.”

  

 

Media Contact

 

Marianna Papadakis

marianna@mtmm.net.au

Ph: 0414 729 006



Also in News and Media

PERKii's gut instinct: Delivering REAL priobiotic goodness to your gut
PERKii's gut instinct: Delivering REAL priobiotic goodness to your gut

In our final Art of the Startup series for 2021 we connect with one of our all time favourite investee companies, Perkii Probiotics and it's CEO Anthony Davie. 

 

Read More
PERKii ranked 18 in the Smart50 Awards 2021
PERKii ranked 18 in the Smart50 Awards 2021

Over the past three financial years, PERKii Targeted Release Probiotics has seen stellar growth, increasing revenue from $1.1 million for the 2018-19 financial year to $3.2 million in 2020-21, with now over 10,000 distribution points & an in-store presence in Coles, Coles Express, Woolworths and Costco.
Read More
Digital health startup Cardihab is changing clinical care for people with cardiac disease
Digital health startup Cardihab is changing clinical care for people with cardiac disease

This week’s Art of the Startup features Cardihab, a transformative Australian startup at the forefront of digital health. Cardihab’s patient-centred virtual care platform provides a new solution that is engaging more patients in life changing cardiac rehabilitation.
Read More